C. cS5A F positive offspring was detected by a 952 bp PCR amplification fragment on genomic DNA using transgene specific primers. D. Detection of cS5A F copy number in transgenic mice (n=3) by Southern blot signal intensity. 4.7 kB band refers to endogenous Stat5 and a 2. Supplementary Table S5 (only adj. P-value≤.0.05, combined score is log(P-value ) x Z-score).
Supplementary Figure 6. Expression of STAT5 in PTCL cases
A. STAT5A (top) and STAT5B (bottom) staining of representative PTCL, NOS; AITL; and background.
Testing cS5A F in vitro
The IL-3 dependent murine B-cell progenitor cell line Ba/F3 was used for testing the cS5A 
Cell Culture
Cells were grown at 37°C and 5% CO 2 in standard medium (RPMI1640 or DMEM, details below).
Murine cell lines: Ba/F3 cells and its derivatives expressing cS5A F or BCR-ABL p210 3 were cultured in RPMI-1640 medium supplemented with 10% FCS, L-Glutamine (2 mM), penicillin/streptomycin (10 U/ml) (all Gibco, ThermoFisher, Waltham, Massachusetts, USA) with or without IL-3 (2 ng/ml, 
mRNA isolation and qRT-PCR
For murine cells, mRNA was isolated from cell pellets using TRIzol ® (Invitrogen, ThermoFisher, Waltham, Massachusetts, USA). For patient derived samples, deparaffinization of formalin-fixed, paraffin embedded (FFPE) sections was performed using xylol extraction (Sigma) followed by isolation of RNA using the miRNeasy kit (Qiagen, Hilden, Germany) according to manufacturer's protocol. First strand cDNA synthesis from isolated RNA was done using the RevertAid TM H Minus First Strand cDNA Synthesis Kit (Fermentas) using gene specific primers for FFPE samples (see supplementary Table S1 ). qRT-PCR was performed on a RealPexcycler (Eppendorf) using SYBR green (Roche, Basel, Switzerland) incorporation and mRNA levels were normalized for murine or human Glyceraldehyde 3-phosphate dehydrogenase (Gapdh), respectively. PTCL FFPE samples with GAPDH ΔCt values >30 were excluded (RNA degradation). Relative fold expression was calculated using the ΔCt method. Primer pairs are listed in Supplementary Table S1 .
Immunohistochemistry
Mouse organs were fixed overnight in 4% phosphate buffered formaldehyde solution (Roti ® Histofix, Carl Roth, Karlsruhe, Germany), dehydrated, paraffin embedded and cut. For immunohistochemical stainings, heat-mediated antigen retrieval was performed in citrate buffer at pH 6.0 (S1699; Dako, Agilent Technologies, Santa Clara, California, USA) and stained with antibodies against CD3, and Ki67 (listed in Supplementary Table S4) using standard protocols.
Human lymphoma cases were incubated overnight at 4 °C with STAT5A, STAT5B, or pYSTAT5
antibodies (listed in Supplementary Table S4 ). For STAT5A and STAT5B, a polymer-based detection system was used (Lab Vision™ UltraVision™ LP Detection System, Thermo Scientific), for pYSTAT5 an Avidin-Biotin system was used. The specific signals were amplified with AEC under visual control followed by counterstaining with Hemalaun.
For Ki67 and CD3 quantification, at least five different high-power field sections (x200 objective) of infiltrated organ areas or corresponding wildtype (wt) areas per mouse and genotype were compared using HistoQuest (TissueGnostics GmbH, Vienna, Austria) quantification software as described. 7 For nuclear STAT5A/B staining intensity quantification, high-power field sections (x200 objective) were obtained for each sample and analyzed with HistoQuest or StrataQuest (TissueGnostics GmbH) quantification software as described. 7 In brief, cut-offs (to differentiate between positive and negative cells) were set for all samples and the resulting positive nuclear STAT5A/B intensities were normalized to Hemalaun staining intensity and used for scoring based on the following intervals:
STAT5A score 1 MI≤55, score 2 55<MI≤75, sore 3 75<MI≤95, score 4 95<MI≤115; STAT5B score 1 MI≤45, score 2 45<MI≤80, sore 3 80<MI≤115, score 4 115<MI≤150 or scoring weak positive, positive, strong positive.
RNA-seq processing, analysis and gene set enrichment analysis

CD8
+ T-cells were enriched using CD8 + Magnisort kit (eBioscience, Santa Clara, California, USA) and mRNA was isolated using Trizol (Sigma-Aldrich, St. Louis, Missouri, USA) in combination with RNeasy mini kit (Qiagen, Hilden, Germany). mRNA library preparation (SENSE mRNA-Seq Library preparation) and RNA sequencing was performed with Illumina HiSeq-2500 at VBCF NGS Unit (www.vbcf.ac.at). Adapter trimming and removal of low quality bases was performed using cutadapt.
After alignment of reads against contaminating sequences (mitochondrial and ribosomal DNA) remaining reads were aligned against GRCm37 using transcriptome guided alignment with TopHat version 1.4.1. Following, htseq-count with mode union was used to get gene counts for union gene models. Then differentially expressed genes (log2 fold change > 2 and FDR q-adjust < 0.1) were determined using DESeq2 version 1.12.4.
For heatmaps, centered and scaled rlog transformed library size normalized counts were visualized using the heatmap.2 function of R package gplots version 3.0.1.
For pathway analysis, the Enrichr 8 web tool was applied. The command-line version of GSEA was used for gene-set enrichment analysis (GSEA), 9, 10 and log-2 fold changes between control and experimental condition were used as ranking metric.
Gene
Hematocytometry and flow cytometry
Blood was obtained by tail incisions or vena facialis puncture collected in EDTA-tubes (Mini-Collect K3EDTA tubes, Greiner Bio-One, Kremsmuenster, Austria) and smears were stained using Modified Wright Staining. White blood cell count and hematocrit were measured using an animal blood counter (sciI Vet abc, Viernheim, Germany). For flow cytometry, erythrocytes were lysed using Gay's solution 
Western blotting
Western blotting was done according to standard methods. Nitrocellulose membranes (Amersham™ Protran, GE Healthcare, Chicago, USA) were incubated with antibodies listed in Supplementary Table   S2 . HSC70 or β-ACTIN served as loading control.
MACS and FACS sorting
Magnetic cell sorting (MACS) was done on single cell suspensions prepared from lymph nodes or spleens using CD4 (L3T4), CD8a (Ly-2), CD19 or CD49b (DX5) microbeads (all anti-mouse and purchased from Miltenyi Biotec, Bergisch Gladbach, Germany) following instructions. FACS sorting of spleen and bone marrow cells or MACS-sorted, 5 days cultured NK cells was performed at 4°C on a FACSAriaII (BD Biosciences) equipped with a 488, 561, 633 and 395 nm laser and FACSDiva software (BD Biosciences) using CD4, CD8, CD19, CD11b, CD3e and NK1.1 antibodies.
Intracellular staining
Intracellular staining of FOXP3 on spleen and lymph nodes was carried out using the T reg staining buffer kit (eBioscience Santa Clara, California, USA) and CD4, CD8 and CD25 antibodies (listed in Supplementary Histopathology of spleen, lung, liver, kidney and pancreas was performed using HE and CD3 staining.
In vivo Ruxolitinib treatment
25 weeks old cS5A hi mice were treated with Ruxolitinib (Chemietek, Indianapolis, Indiana) twice a day at 45 mg/kg dosage via oral gavage for 30 days. Ruxolitinib was dissolved in DMSO (SigmaAldrich. St, Louis, Missouri, USA) and subsequently diluted in 0.5% methylcellulose (w/v, SigmaAldrich).
Supplementary Tables   Supplementary Table S1 : Primers
All primers were obtained from Eurofins MWG/Operon (Ebersberg, Germany). All sequences are written in 5' to 3' direction.
Primers for PCR (cloning)
SfiIStat5a for GCAGGCCCGTACGGCCGAATTCGACTCACAACCCCAG
BclIStat5a rev GCAAACTGAGCTTGGATCCG
NotIER rev GCATCAGCGCGGCCGCCCGCGGTCAGATCGTGTTG
Southern blotting primers
Stat5a-exon 14 for GGCAGGGTGCCATTTGCTGTG
Stat5a-exon 14 rev CCGGTTGAACTGGGACCAGGA
Genotyping Primers
cS5 frw AGGCGACCATCATCAGCGAGC
cS5 rev GAATGGAGAAATCTCGCGTCG qPCR primers -murine
Gapdh frw AGAAGGTGGTGAAGCAGGCATC
Gapdh rev CGGCATCGAAGGTGGAAGAGTG
Stat5a frw ACGCCGGCCCATGGACAGTC
FLAG rev CTTGTCATCGTCGTCCTTGTAGTC
Stat5a for CGAAGCCAACAATTGCAGC
Stat5a rev TCTCCGTGTCCTGTGTGATCAG
Bcl2 frw ACTGAGTACCTGAACCGGCATC
Bcl2 rev GGAGAAATCAAACAGAGGTCGC
Bcl6 frw GATACAGCTGTCAGCCGGG
Bcl6 rev AGTTTCTAGGAAAGGCCGGA
Cis frw CTGGACTCTAACTGCTTGTC
Cis rev TAGGCAGCACCGAGTCAC
Pim1 frw TTCTCCACCGCGACATCAA
Pim1 rev TAGCGAATCCACTCTGGAGGAC qPCR primers -human
STAT5a frw TCTCCTCTGACTTCAACAGCG
STAT5a rev ACCACCCTGTTGCTGTAGCC
STAT5a_RevTrans1 AGGGGGCGAGAGGCGGGAG
STAT5b frw GATCAAGCAAGTGGTCCC
STAT5 rev CCAGATCGAAGTCCCCATCGG
STAT5b_RevTrans1 CCGCGCTACGTCCATTGTG
GAPDH frw TCTTTTGCGTCGCCAGCCGAG
GAPDH rev GCGCCCAATACGACCAAATCCGTT
GAPDH_RevTrans1 TGACCAGGCGCCCAATACGAC 
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